Zacks Investment Research Upgrades Udg Healthcare (OTCMKTS:UDHCF) to “Buy”

Zacks Investment Research upgraded shares of Udg Healthcare (OTCMKTS:UDHCF) from a hold rating to a buy rating in a research report report published on Friday, January 12th. The brokerage currently has $13.00 price objective on the stock.

According to Zacks, “UDG Healthcare plc provide services to the healthcare industry. The company’s operating segment consists of Ashfield Commercial & Medical Services, Sharp Packaging Services and Supply Chain Services. Ashfield Commercial & Medical Services division provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services. Sharp Packaging Service division provides contract packaging and clinical trial packaging services. Supply Chain Services provides outsourced sales, marketing, distribution and engineering services. UDG Healthcare plc operates primarily in US, UK, Ireland and Germany. UDG Healthcare plc is based in Dublin, the Republic of Ireland. “

Shares of Udg Healthcare (OTCMKTS:UDHCF) traded down $1.07 during midday trading on Friday, hitting $10.89. The stock had a trading volume of 1,700 shares, compared to its average volume of 2,580. Udg Healthcare has a twelve month low of $10.89 and a twelve month high of $12.65.

ILLEGAL ACTIVITY NOTICE: This report was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this report on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The legal version of this report can be viewed at https://www.dispatchtribunal.com/2018/02/05/udg-healthcare-udhcf-upgraded-to-buy-by-zacks-investment-research.html.

About Udg Healthcare

UDG Healthcare plc, together with its subsidiaries, provides clinical, commercial, communication, and packaging services to the healthcare industry in the Republic of Ireland, the United Kingdom, North America, and continental Europe. It operates through three segments: Ashfield, Sharp, and Aquilant.

Get a free copy of the Zacks research report on Udg Healthcare (UDHCF)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Udg Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply